This event likely links with the HRD onsetting LOH of chr17q in tumors with BRCA1 deficiency, which is more prevalent in dHpC tumor types such as breast and ovarian cancers (Figure 4A). This evidence concerns the gene BRCA1 and ovarian cancer.